Kite Pharma Obtains $15,000,000 Series A Funding Round

  • Feed Type
  • Date
    3/9/2011
  • Company Name
    Kite Pharma
  • Mailing Address
    10924 Le Conte Avenue Los Angeles, CA 90024
  • Company Description
    Kite Pharma, Inc. is a privately held development stage biotechnology company engaged in the design and development of pioneering immune-based targeted therapies to treat different cancer indications. Kite has a portfolio of proprietary product candidates designed to stimulate the patient’s own immune system to fight tumor cells.
  • Website
    http://www.kitepharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $15,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    The funds will allow us to grow the company, advance our products into clinical development and to expand our pre-clinical pipeline.
  • M&A Terms
  • Venture Investor
    TPG Capital
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.